advertisement
Savient Pharma initiated with "market outperform"
06/17/09 - JMP Securities
NEW YORK, June 17 (newratings.com) - Analysts at JMP Securities initiate coverage of Savient Pharma (SVNT) with a "market outperform" rating. The target price is set to $15.
Share Recommend this article to a friend
add SVNT to my stocks and get e-mail alerts on Savient Pharmaceuticals Inc.
News